Since ATP6AP1 levels correlated negatively with CD8+ T cell and B cell levels in the present study, high ATP6AP1 expression in BC tissues may inhibit the cytotoxic response to tumor cells, resulting in poor outcomes. Here, CD8A is linked to neoplasm.